Transcatheter Aortic Valve Implantation in Pure Aortic Insufficiency, An Option for High-Risk Patients

Transcatheter Aortic Valve Implantation (TAVI) is a technique of widely known cardiac structural interventionism, which has been become one of the mainstays of treatment for patients with stenosis aortic, with evidence supporting its use regardless of risk surgical. For patients with severe symptomatic aortic regurgitation, establishes surgical intervention as the first option; however, the current management guidelines do not provide management recommendations percutaneous. Advances in valve technology and experience accumulated have encouraged the use of TAVI in other settings outside its indication by technical sheet, when the patient is not eligible for surgery due to discharge comorbidity, and one of these off-label indications is aortic insufficiency. We report the first case of transcatheter aortic valve implantation in patient diagnosed with pure aortic regurgitation on the caribbean coast Colombian.